Expression of Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) in Acute and Chronic Inflammation
Overview
Affiliations
The objective of this study was to quantify, in vivo, constitutive and tumor necrosis factor alpha (TNF-alpha)-enhanced expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in different tissues from healthy wild-type mice (C57BL/6) as well as interleukin-10 (IL-10)-deficient mice with and without active colitis. Using the dual radiolabel monoclonal antibody technique, we found substantial constitutive expression of MAdCAM-1 in the intestine, colon, and mesenteric lymph nodes. MAdCAM-1 expression in these tissues was significantly enhanced, in a time-dependent manner, by systemic administration of TNF-alpha. Maximum surface expression was observed at 18 h after TNF-alpha administration and remained significantly elevated at 48 h post-TNF-alpha injection. No significant constitutive nor TNF-alpha-induced expression of MAdCAM-1 was detected in skeletal muscle, brain, or heart. In IL-10-deficient (IL-10 k/o) mice with no clinical or histological evidence of colitis, constitutive and TNF-alpha-induced expression of MAdCAM-1 in the intestine, cecum, and colon was not different from those values obtained with healthy wild-type controls. IL-10-deficient mice with active colitis exhibited a four- to fivefold greater expression of MAdCAM-1 in the cecum and colon compared with their healthy controls or to IL-10 k/o mice with no evidence of colitis. Taken together, these data demonstrate that TNF-alpha enhances surface expression of MAdCAM-1 in intestinal and colonic tissues to the same extent in both wild-type and IL-10 k/o mice with no colonic inflammation, whereas IL-10 k/o mice with active colitis exhibited a profound up-regulation of MAdCAM-1 in the colon.
Ruminski P, Rettig M, Dipersio J Biomolecules. 2024; 14(8).
PMID: 39199390 PMC: 11353233. DOI: 10.3390/biom14081003.
ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity.
Kozlovski S, Regev O, Sapoznikov A, Kizner M, Achdout H, Petrovich-Kopitman E Front Immunol. 2023; 13:1041552.
PMID: 36895258 PMC: 9988921. DOI: 10.3389/fimmu.2022.1041552.
Shibrya E, Rashed R, Abd El Fattah M, El-Ghazaly M, Kenawy S Dose Response. 2023; 21(1):15593258231155787.
PMID: 36756150 PMC: 9900677. DOI: 10.1177/15593258231155787.
Jensen S, Sheikh M, Akkouh I, Szabo A, OConnell K, Lekva T Schizophr Bull. 2022; 49(3):635-645.
PMID: 36462169 PMC: 10154716. DOI: 10.1093/schbul/sbac191.
Cluny N, Nyuyki K, Almishri W, Griffin L, Lee B, Hirota S J Neuroinflammation. 2022; 19(1):73.
PMID: 35379260 PMC: 8981853. DOI: 10.1186/s12974-022-02431-z.